1. Home
  2. Labeler Index
  3. Taro Pharmaceuticals U.s.a., Inc.
  4. 51672-4043
  5. NDC Package Code: 51672-4043-3 Clorazepate Dipotassium

NDC Package 51672-4043-3 Clorazepate Dipotassium

Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
51672-4043-3
Package Description:
1000 TABLET in 1 BOTTLE
Product Code:
51672-4043
Proprietary Name:
Clorazepate Dipotassium
Non-Proprietary Name:
Clorazepate Dipotassium
Substance Name:
Clorazepate Dipotassium
Usage Information:
Clorazepate is used to treat anxiety, acute alcohol withdrawal, and seizures. This medication belongs to a class of drugs called benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. It works by enhancing the effects of a certain natural chemical in the body (GABA).
11-Digit NDC Billing Format:
51672404303
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Taro Pharmaceuticals U.s.a., Inc.
Dosage Form:
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route(s):
Oral - Administration to or by way of the mouth.
Active Ingredient(s):
CLORAZEPATE DIPOTASSIUM 7.5 mg/1
Pharmacologic Class(es):
DEA Schedule:
Schedule IV (CIV) Substances
Sample Package:
No
FDA Application Number:
ANDA075731
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
04-27-2000
Listing Expiration Date:
12-31-2025
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package CodePackage Description
51672-4043-1100 TABLET in 1 BOTTLE
51672-4043-2500 TABLET in 1 BOTTLE

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 51672-4043-3?

The NDC Packaged Code 51672-4043-3 is assigned to a package of 1000 tablet in 1 bottle of Clorazepate Dipotassium, a human prescription drug labeled by Taro Pharmaceuticals U.s.a., Inc.. The product's dosage form is tablet and is administered via oral form.

Is NDC 51672-4043 included in the NDC Directory?

Yes, Clorazepate Dipotassium with product code 51672-4043 is active and included in the NDC Directory. The product was first marketed by Taro Pharmaceuticals U.s.a., Inc. on April 27, 2000 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 51672-4043-3?

The 11-digit format is 51672404303. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-151672-4043-35-4-251672-4043-03